Nicolas Miguet (XPAR:MLNMA) Research & Development: € Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLNMA Nicolas Miguet XPAR:MLNMA
27 GF Score
Price €0.18
! 1 Warning Sign
View Full Analysis

What is Nicolas Miguet Research & Development?

Nicolas Miguet XPAR:MLNMA 27 Research & Development is € Mil as of Dec. 2025. GuruFocus rates XPAR:MLNMA with a GF Score™ of 27/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nicolas Miguet's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Nicolas Miguet does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2025.

Nicolas Miguet  (XPAR:MLNMA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nicolas Miguet Research & Development Related Terms

Nicolas Miguet Research & Development Historical Data

* Premium members only.

The historical data trend for Nicolas Miguet's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nicolas Miguet Research & Development Chart

Nicolas Miguet Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00

Nicolas Miguet Semi-Annual Data
Dec23 Dec24 Dec25
Research & Development 0.00 0.00 0.00
XPAR:MLNMA
27GF Score
Nicolas Miguet XPAR:MLNMA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nicolas Miguet Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
Nicolas Miguet (XPAR:MLNMA) has a Research & Development of € Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nicolas Miguet and its competitors.
Is Nicolas Miguet's Research & Development too high?
Nicolas Miguet's current Research & Development is € Mil. Overall, Nicolas Miguet has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Nicolas Miguet's Research & Development compare to SPGI and CME?
Nicolas Miguet's Research & Development of € Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nicolas Miguet and its competitors. Nicolas Miguet's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nicolas Miguet stock overvalued right now?
Nicolas Miguet (XPAR:MLNMA) has a current Research & Development of € Mil. The current Research & Development is € Mil. Nicolas Miguet's overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nicolas Miguet (XPAR:MLNMA), the current Research & Development is € Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nicolas Miguet Business Description

Address Moulin de la Tour Grise, Vernueil d'Avre et d'Iton, FRA, 27130
Nicolas Miguet is engaged in stock exchange consulting. The company produces stock exchange information and distributes it through various media, including the press, the Internet, and the telephone.
27GF Score

Get the complete analysis for XPAR:MLNMA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price